Home > > > > Report Detail

Global (United States, European Union and China) Alpha-1 Antitrypsin Drugs Market Research Report 2019-2025

Publisher Name :
Date: 16-May-2019
No. of pages: 117
Inquire Before Buying

In 2019, the market size of Alpha-1 Antitrypsin Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alpha-1 Antitrypsin Drugs.

This report studies the global market size of Alpha-1 Antitrypsin Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Alpha-1 Antitrypsin Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Baxter

- CSL Behring

- Grifols

- Kamada

- Abeona Therapeutics

- Alnylam Pharmaceuticals

- Applied Genetic Technologies Corp

- Arrowhead Research Corporation

- Baxalta

Market Segment by Product Type

- Parenteral

- Inhalation

Market Segment by Application

- Drugstore

- Hospital

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Alpha-1 Antitrypsin Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Alpha-1 Antitrypsin Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Alpha-1 Antitrypsin Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Alpha-1 Antitrypsin Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Parenteral
1.3.3 Inhalation
1.4 Market Segment by Application
1.4.1 Global Alpha-1 Antitrypsin Drugs Market Share by Application (2019-2025)
1.4.2 Drugstore
1.4.3 Hospital
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Drugs Market Size
2.1.1 Global Alpha-1 Antitrypsin Drugs Revenue 2014-2025
2.1.2 Global Alpha-1 Antitrypsin Drugs Sales 2014-2025
2.2 Alpha-1 Antitrypsin Drugs Growth Rate by Regions
2.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Regions 2014-2019
2.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers
3.1.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers 2014-2019
3.1.2 Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Alpha-1 Antitrypsin Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Alpha-1 Antitrypsin Drugs Price by Manufacturers
3.4 Key Manufacturers Alpha-1 Antitrypsin Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
3.6 Key Manufacturers Alpha-1 Antitrypsin Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Parenteral Sales and Revenue (2014-2019)
4.1.2 Inhalation Sales and Revenue (2014-2019)
4.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type
4.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type
4.4 Alpha-1 Antitrypsin Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Alpha-1 Antitrypsin Drugs Sales by Application
6 United States
6.1 United States Alpha-1 Antitrypsin Drugs Breakdown Data by Company
6.2 United States Alpha-1 Antitrypsin Drugs Breakdown Data by Type
6.3 United States Alpha-1 Antitrypsin Drugs Breakdown Data by Application
7 European Union
7.1 European Union Alpha-1 Antitrypsin Drugs Breakdown Data by Company
7.2 European Union Alpha-1 Antitrypsin Drugs Breakdown Data by Type
7.3 European Union Alpha-1 Antitrypsin Drugs Breakdown Data by Application
8 China
8.1 China Alpha-1 Antitrypsin Drugs Breakdown Data by Company
8.2 China Alpha-1 Antitrypsin Drugs Breakdown Data by Type
8.3 China Alpha-1 Antitrypsin Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Alpha-1 Antitrypsin Drugs Breakdown Data by Company
9.2 Rest of World Alpha-1 Antitrypsin Drugs Breakdown Data by Type
9.3 Rest of World Alpha-1 Antitrypsin Drugs Breakdown Data by Application
9.4 Rest of World Alpha-1 Antitrypsin Drugs Breakdown Data by Countries
9.4.1 Rest of World Alpha-1 Antitrypsin Drugs Sales by Countries
9.4.2 Rest of World Alpha-1 Antitrypsin Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.1.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.1.5 Baxter Recent Development
10.2 CSL Behring
10.2.1 CSL Behring Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.2.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.2.5 CSL Behring Recent Development
10.3 Grifols
10.3.1 Grifols Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.3.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.3.5 Grifols Recent Development
10.4 Kamada
10.4.1 Kamada Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.4.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.4.5 Kamada Recent Development
10.5 Abeona Therapeutics
10.5.1 Abeona Therapeutics Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.5.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.5.5 Abeona Therapeutics Recent Development
10.6 Alnylam Pharmaceuticals
10.6.1 Alnylam Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.6.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.6.5 Alnylam Pharmaceuticals Recent Development
10.7 Applied Genetic Technologies Corp
10.7.1 Applied Genetic Technologies Corp Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.7.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.7.5 Applied Genetic Technologies Corp Recent Development
10.8 Arrowhead Research Corporation
10.8.1 Arrowhead Research Corporation Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.8.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.8.5 Arrowhead Research Corporation Recent Development
10.9 Baxalta
10.9.1 Baxalta Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Alpha-1 Antitrypsin Drugs
10.9.4 Alpha-1 Antitrypsin Drugs Product Introduction
10.9.5 Baxalta Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Alpha-1 Antitrypsin Drugs Sales Channels
11.2.2 Alpha-1 Antitrypsin Drugs Distributors
11.3 Alpha-1 Antitrypsin Drugs Customers
12 Market Forecast
12.1 Global Alpha-1 Antitrypsin Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type
12.3 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application
12.4 Alpha-1 Antitrypsin Drugs Forecast by Regions
12.4.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Alpha-1 Antitrypsin Drugs Product Picture
Table Alpha-1 Antitrypsin Drugs Key Market Segments
Table Major Manufacturers Alpha-1 Antitrypsin Drugs Covered in This Report
Table Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Shar by Type 2014-2025
Figure Parenteral Figures
Table Major Manufacturers of Parenteral
Figure Inhalation Figures
Table Major Manufacturers of Inhalation
Table Global Alpha-1 Antitrypsin Drugs Market Share by Application 2019-2025 (K Units)
Figure Drugstore Use Case
Figure Hospital Use Case
Figure Others Use Case
Figure Alpha-1 Antitrypsin Drugs Report Years Considered
Figure Global Alpha-1 Antitrypsin Drugs Market Size 2014-2025 (Million US$)
Figure Global Alpha-1 Antitrypsin Drugs Sales 2014-2019 (K Units)
Table Global Alpha-1 Antitrypsin Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Alpha-1 Antitrypsin Drugs Sales by Regions 2014-2019 (K Units)
Table Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions in 2019
Table Global Alpha-1 Antitrypsin Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers in 2019
Table Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2014-2019)
Figure Alpha-1 Antitrypsin Drugs Value Share by Manufacturers in 2019
Table Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Alpha-1 Antitrypsin Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Alpha-1 Antitrypsin Drugs Plants/Factories Distribution
Table Key Manufacturers Alpha-1 Antitrypsin Drugs Area Served
Table Date of Key Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
Table Key Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Parenteral Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Inhalation Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Alpha-1 Antitrypsin Drugs Sales by Type (2014-2019) (K Units)
Table Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2018
Table Global Alpha-1 Antitrypsin Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type in 2018
Table Alpha-1 Antitrypsin Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Alpha-1 Antitrypsin Drugs Sales by Application (2014-2019) (K Units)
Table Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2014-2019)
Figure Global Sales Alpha-1 Antitrypsin Drugs Market Share by Application (2014-2019)
Figure Global Sales Alpha-1 Antitrypsin Drugs Market Share by Application (2014-2019)
Figure United States Alpha-1 Antitrypsin Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Alpha-1 Antitrypsin Drugs Sales by Company (2014-2019) (K Units)
Table United States Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2014-2019)
Figure United States Alpha-1 Antitrypsin Drugs Sales Market Share by Company in 2019
Table United States Alpha-1 Antitrypsin Drugs Sales by Type (2014-2019) (K Units)
Table United States Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2014-2019)
Figure United States Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Table United States Alpha-1 Antitrypsin Drugs Sales by Application (2014-2019) (K Units)
Table United States Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2014-2019)
Figure United States Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure European Union Alpha-1 Antitrypsin Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Alpha-1 Antitrypsin Drugs Sales by Company (2014-2019) (K Units)
Table European Union Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2014-2019)
Figure European Union Alpha-1 Antitrypsin Drugs Sales Market Share by Company in 2019
Table European Union Alpha-1 Antitrypsin Drugs Sales by Type (2014-2019) (K Units)
Table European Union Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Alpha-1 Antitrypsin Drugs Market Share by Type
Table European Union Alpha-1 Antitrypsin Drugs Sales by Application (2014-2019) (K Units)
Table European Union Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Alpha-1 Antitrypsin Drugs Market Share by Application
Figure China Alpha-1 Antitrypsin Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Alpha-1 Antitrypsin Drugs Sales by Company (2014-2019) (K Units)
Table China Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2014-2019)
Figure China Alpha-1 Antitrypsin Drugs Sales Market Share by Company in 2019
Table China Alpha-1 Antitrypsin Drugs Sales by Type (2014-2019) (K Units)
Table China Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2014-2019)
Figure China Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Table China Alpha-1 Antitrypsin Drugs Sales by Application (2014-2019) (K Units)
Table China Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2014-2019)
Figure China Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure Rest of World Alpha-1 Antitrypsin Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Alpha-1 Antitrypsin Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Company in 2019
Table Rest of World Alpha-1 Antitrypsin Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Table Rest of World Alpha-1 Antitrypsin Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Table Rest of World Alpha-1 Antitrypsin Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Alpha-1 Antitrypsin Drugs Sales Market Share by Countries in 2019
Table Rest of World Alpha-1 Antitrypsin Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Alpha-1 Antitrypsin Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Alpha-1 Antitrypsin Drugs Revenue Market Share by Countries in 2019
Figure Japan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Baxter Company Details
Table Baxter Description and Business Overview
Table Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Baxter Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Baxter Recent Development
Table CSL Behring Company Details
Table CSL Behring Description and Business Overview
Table CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Behring Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table CSL Behring Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table CSL Behring Recent Development
Table Grifols Company Details
Table Grifols Description and Business Overview
Table Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Grifols Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Grifols Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Grifols Recent Development
Table Kamada Company Details
Table Kamada Description and Business Overview
Table Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kamada Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Kamada Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Kamada Recent Development
Table Abeona Therapeutics Company Details
Table Abeona Therapeutics Description and Business Overview
Table Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Abeona Therapeutics Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Description and Business Overview
Table Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Alnylam Pharmaceuticals Recent Development
Table Applied Genetic Technologies Corp Company Details
Table Applied Genetic Technologies Corp Description and Business Overview
Table Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Applied Genetic Technologies Corp Recent Development
Table Arrowhead Research Corporation Company Details
Table Arrowhead Research Corporation Description and Business Overview
Table Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Arrowhead Research Corporation Recent Development
Table Baxalta Company Details
Table Baxalta Description and Business Overview
Table Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxalta Alpha-1 Antitrypsin Drugs Sales Growth Rate (2014-2019)
Table Baxalta Alpha-1 Antitrypsin Drugs Sales Market Share in Global Market
Table Baxalta Recent Development
Figure Alpha-1 Antitrypsin Drugs Value Chain
Table Alpha-1 Antitrypsin Drugs Distributors List
Table Alpha-1 Antitrypsin Drugs Customers List
Table Global Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure China Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure India Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Alpha-1 Antitrypsin Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Alpha-1 Antitrypsin Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs